All
New Study Examines Connection Between Formulation and Benzene Levels in BPO Products
Barbieri et al evaluated product use, benzoyl peroxide concentration, days until expiration, and more.
POLL: Looking Ahead to Winter Clinical Hawaii 2025
Are you attending Winter Clinical Hawaii? Answer our poll below to let us know.
The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS
Hawkes discusses urticaria subtypes, treatments, and emerging therapies like dupilumab and remibrutinib.
Daily Derm Times: February 12, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Post-Hoc Analysis of ALLEGRO-2b/3 Trial Highlights Patient-Reported Outcome Improvements
Clinicians observed a positive relationship between scalp hair regrowth and downstream treatment benefits for patients with alopecia areata.
Should “Advanced Practice Provider” Represent Both PAs and NPs?
Uniting all professions should be the goal as it concerns the patient and the access to care.
MOPD 2025: Complete Conference Recap
Catch up on coverage from the 2025 Masters of Pediatric Dermatology held in Miami Beach, Florida.
Trauma-Induced Melanocyte Implantation Leading to Subcutaneous Melanoma
Trauma-induced melanocyte implantation can lead to subcutaneous melanoma, mimicking melanoma of unknown primary but with distinct diagnostic criteria.
Reviewing Complex Cases: Special Issues in AD Comorbidities
At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a woman aged 27 years who had eczematous lesions covering more than 20% of her BSA.
Expert Insights on Personalizing Atopic Dermatitis Treatment
New drugs targeting IL-4, IL-13, and IL-31 pathways provide options for tailored eczema treatments.
Topical TCA and Methoxsalen Not Clinically Effective for Acral Vitiligo
Each treatment saw very mild clinical and dermatologic responses with low levels of patient satisfaction.
Journal Digest: February 12
This review of the latest dermatologic studies includes insights into endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa; forms of hair loss among individuals with anxiety disorder; and more.
Daily Derm Times: February 11, 2025
SBS 2025: Complete Conference Recap
Catch up on coverage from the 2025 South Beach Symposium held in Miami Beach, Florida.
Closing the Wound Care Gap: Addressing Disparities in Amputations and Limb Preservation
Recent technological advancements such as the development and use of human cellular and tissue-based products and advanced skin substitutes have transformed limb preservation.
Practice What You Preach: A Clinician's Guide to Chemical Peels
Dobkin underwent the procedure in order to connect with his patients considering it for themselves.
Botox Cosmetic: Ethics, Empowerment, and Innovation
Botox Cosmetic has evolved from its accidental discovery to a leading treatment in dermatology, balancing medical innovation with ethical considerations.
Education Drives Success in Atopic Dermatitis Treatment
A recent expert discussion highlighted the importance of long-term planning, including when and how to adjust or transition therapies.
Information on TikTok About Spironolactone is Unreliable, New Study Finds
The top videos under the hashtag, #spironolactone” had low scores on the mDISCERN and GQS scales, according to Adam Friedman, MD, FAAD, senior author of the study.
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.
Developing Personalized Approaches for Atopic Dermatitis Treatment
Tina Bhutani-Jacques, MD, highlighted the importance of individualized and informative care while building trust among patients and caregivers.
Top 5 Articles of the Week: February 2-7
Explore the top headlines of the week including Allergan Aesthetics' new AA Signature program, the launch of EltaMD's new UV Skin Recovery broad spectrum SPF 50 face sunscreens, and more.
Beyond the Surface: How Skin Conditions Affect Daily Life
Lio emphasizes that patient comfort and understanding are essential for successful treatment outcomes.
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Nektar Therapeutics’ investigational biologic targets the IL-2 receptor complex.
Topical Corticosteroids: Potency, Vehicles, and Best Practices
Many patients, especially parents of pediatric patients, exhibit steroid phobia, impacting treatment adherence.
Optimizing Rural Dermatology: Lisa Swanson, MD, FAAD, on Effective Care Strategies
Swanson shared strategies for treating rural dermatology patients at MOPD 2025, emphasizing effective initial care, the role of telehealth, and practical treatments.
Bunick Highlights Efficacy and Safety of JAK Inhibitors
Long-term safety data suggests that JAK inhibitors have a lower risk of cardiovascular and thromboembolic events than previously thought.
South Beach Symposium 2025: A Comprehensive Dermatology Event
Medical and aesthetic dermatologists partner at SBS 2025 to bridge gaps between clinical care and cosmetic procedures.
Tackling Skin Laxity and Pigmentation: Technologies in Focus at SBS 2025
Michael Gold, MD, explored microneedling innovations, pulse wave technology for pigmentation, and the aesthetic effects of GLP-1 receptor agonists, including "Ozempic face" and skin laxity.
Day 3 Recap: SBS 2025
Catch up on coverage from the third day of the 2025 South Beach Symposium held in Miami Beach, Florida.